Risk. It is a fact of life for a trader. Without risk, there is no reward. Risk is not a bad thing in and of itself. However, you must quantify and manage your risk. In this video, I explain how to identify and manage the risk of a credit spread that is in the money […]
Read Article
As of this post, we are in day two of a monstrous move in the markets. I would love to believe that the overextended downside moves are finally starting to see some relief. I do, however, worry that we may just be seeing some end-of-the-month lipstick being put on the pig…I mean bear behavior. Yes, […]
Read Article
Once again, Titan Pharmaceuticals (TTNP) was busy in trading. The stock has been volatile overall, with strong moves up and down. Today, the stock initially opened under downward pressure and appeared that it might trade below $0.30 per share during the first hour of the session. However, towards the middle of the session, the stock […]
Read Article
The markets have been scary lately. Will there be more pain for investors or will we see a relief rally on the horizon? Investors may not like my commentary. Unfortunately, I was right the first time in my assessment. Will I be correct again?
Read Article
As the S&P 500 closed in the red for three-quarters of October’s trading sessions so far, the current narrative has been bleak: Q3 earnings season is a flop for markets. Reports from General Electric (NYSE:GE) and Facebook (NASDAQ:FB) today will kick off the last big week for quarterly results, though U.S. stock index futures are still […]
Read Article
Titan Pharmaceuticals (TTNP) was in the news once again. After news hit the wires this morning that Canadian company Knight Therapeutics launched PROBUPHINE for treatment of opioid disorder, TTNP shares rallied over 13.2% higher pre-market. Knight has exclusive rights to distribute PROBUPHINE per an agreement with TTNP. However, TTNP shares retraced the overnight gains throughout […]
Read Article
In last Friday’s video, I described several support levels to watch for if there was continued weakness. In a way, one can argue that today’s action is worse than the run-of-the-mill decline because it happened on a day that had a VERY strong open. The Dow was +300 at one point this morning…and then suffered […]
Read Article
U.S. stock index futures are staging a comeback despite lingering concerns over rate hikes, earnings, and global growth. Stocks fell sharply on Friday as investors slogged through another volatile session on Wall Street, which saw the S&P 500 end at its lowest level since early May and flirt with correction territory. Traders are now eyeing reports […]
Read Article
In today’s video, I discuss some major support areas in the S&P 500. Did the market reach one Friday near its lows? Will traders sell positions into the close because they don’t want to be long through the weekend? If it doesn’t hold, the levels mentioned in the video will be even more important.
Read Article
The big surprise today in the biotech/healthcare space was ESPR, Esperion Therapeutics. After trading up over 8% higher in the pre-market, the stock promptly sold off its gains after the bell. But then, towards the middle of the day, the stock proceeded to rally not only to recoup its lost gains but to press up […]
Read Article
